ALNY
Alnylam Pharmaceuticals, Inc.
$309.66
$41.32B market cap
Scanner Membership
0 active right now.
200 Weekly MA
Not in scan
Ascending Triangle
Not in scan
Bull Flag
Not in scan
Earnings-Price Divergence
Not in scan
Free Cash Flow Value
Not in scan
Minervini Trend Template
Not in scan
Quiet Accumulation
Not in scan
The Golden Pocket
Not in scan
VCP
Not in scan
Weinstein Stage 2 Breakout
Not in scan
Price
$309.66
52W High
$491.22
52W Low
$230.50
SMA50
$323.37
SMA200
$393.62
Avg Volume 50D
$1.24M
From 52W High
-58.63%
From 52W Low
+34.34%
Vs SMA50
-4.24%
Vs SMA200
-21.33%
Current Volume
$1.50M
Bars Stored
1256
Market Cap
$41.32B
P/E
131.7x
Revenue TTM
$3.71B
EPS TTM
2.27
Net Income TTM
$313.75M
Free Cash Flow
$465.38M
Revenue 1Y
+65.19%
EPS 1Y
+204.61%
Net Income 1Y
+212.79%
FCF 1Y
+1192.73%
Profit Margin
8.45%
FCF Margin
12.53%
Revenue
Quarterly ending 2025-12-31
$1.10B
EPS
Quarterly ending 2025-12-31
1.38
Net Income
Quarterly ending 2025-12-31
$186.42M